| 摘要 |
The present invention relates to a method for producing partially matured dendritic cells having an increased expression of interleukin IL-12, to partially matured dendritic cells produced by this method, to a pharmaceutical composition comprising the produced partially matured dendritic cells, and to the use of the produced partially matured dendritic cells for the manufacture of a medicament to treat and/or prevent cancer and/or microbial or parasitic infections. |
